<DOC>
	<DOCNO>NCT00277342</DOCNO>
	<brief_summary>The investigator hypothesise common A277G polymorphism liver fatty acid bind protein ( L-FABP ) gene , lead amino acid exchange , may associate alteration lipid-induced hepatic insulin resistance . In present study investigator investigate potential difference lipid-induced hepatic insulin resistance , relation glycogenolysis gluconeogenesis , healthy subject A277G polymorphism vs. subject carry wildtype .</brief_summary>
	<brief_title>Potential Association Common L-FABP Polymorphism With Lipid-induced Hepatic Insulin Resistance</brief_title>
	<detailed_description>Liver fatty acid bind protein ( L-FABP ) abundant cytosolic lipid-binding protein regulate lipid transport metabolism . Only one common non-synonymous polymorphism ( A227G ) lead amino-acid exchange exonic region L-FABP gene previously identify . Experimental elevation free fatty acid ( FFAs ) show impair insulin mediate suppression endogenous glucose production ( EGP ) . Deletion L-FABP gene show obvious phenotype mouse receive low fat chow diet , lead decrease hepatic triglyceride accumulation prolong fasted state , expose mouse increase fatty acid flux liver . The function L-FABP gene may alter polymorphism cod region gene , probably lead modification hepatic triglyceride accumulation hepatic insulin resistance.We hypothesize carrier A277G SNP , compare match wild-type subject , may show altered response hepatic glucose production upon exposure increase peripheral fatty acid concentration , achieve lipid / heparin infusion . Because know free fatty acid potently increase insulin secretion , use somatostatin clamps experiment , follow replacement postabsorptive insulin glucagon concentration .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>healthy subject normal glucose tolerance ( NGT ) severe cardiac , liver , kidney disease pregnant lactate woman , menstrual irregularity cortisone , antidiabetic drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>lipid induce hepatic insulin resistance</keyword>
	<keyword>polymorphism liver fatty-acid-binding-protein</keyword>
	<keyword>gluconeogenesis</keyword>
	<keyword>glycogenolysis</keyword>
	<keyword>endogenous glucose production</keyword>
</DOC>